Contributed By Walder Wyss Ltd
Representation expenses in connection with scientific congresses or promotional events must remain within reasonable limits and be of subordinate importance in relation to the main purpose of the event. They may not benefit persons who are not healthcare professionals authorised to prescribe, dispense or use medicines for professional means at their own responsibility (Article 11 AWV).
The Pharma Code states that events that are organised or receive financial support (sponsored) from pharmaceutical companies with subsidiaries in Switzerland and that are aimed purely at participants from Switzerland should, in principle, take place in Switzerland. Refreshments or meals (including beverages) may be offered only to the participants of the event and must be modest and reasonable according to the customary local standards (in Switzerland: maximum of CHF150 per healthcare professional per meal). The events should take place at appropriate venues conducive to the main purpose of the event and not be extravagant. Pharmaceutical companies must generally require that participants make an appropriate financial contribution, which may be reduced for healthcare professionals who are still in post-graduate medical training and may be waived for events that are held in Switzerland and that last for less than one day (rules 143.5, 313, 322 et seqq. and 331 et seqq. Pharma Code; Guideline II. 6 of the SAMW).